UBS set a €73.00 ($86.90) target price on Lanxess (ETR:LXS) in a research report report published on Monday morning, www.boersen-zeitung.de reports. The brokerage currently has a buy rating on the stock.
LXS has been the subject of several other research reports. Independent Research set a €71.00 ($84.52) target price on shares of Lanxess and gave the company a neutral rating in a research note on Monday, May 7th. Main First Bank set a €65.00 ($77.38) target price on shares of Lanxess and gave the company a sell rating in a research note on Tuesday, April 10th. equinet set a €83.00 ($98.81) target price on shares of Lanxess and gave the company a buy rating in a research note on Thursday, March 15th. Baader Bank set a €75.00 ($89.29) target price on shares of Lanxess and gave the company a neutral rating in a research note on Tuesday, February 6th. Finally, Credit Suisse Group set a €72.70 ($86.55) target price on shares of Lanxess and gave the company a neutral rating in a research note on Thursday, January 25th. One research analyst has rated the stock with a sell rating, sixteen have given a hold rating and eight have issued a buy rating to the stock. The stock has an average rating of Hold and a consensus price target of €71.39 ($84.99).
Shares of ETR:LXS opened at €70.16 ($83.52) on Monday. Lanxess has a 52 week low of €59.89 ($71.30) and a 52 week high of €74.50 ($88.69).
Lanxess Company Profile
LANXESS Aktiengesellschaft develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. It operates in four segments: Advanced Intermediates, Performance Chemicals, High Performance Materials, and ARLANXEO. The Advanced Intermediates segment offers high-grade intermediates for the agrochemicals and coatings industries; fine chemicals as precursors and intermediates for pharmaceuticals, agrochemicals, and specialty chemicals industries; customer-specific specialties; and tire chemicals.
Receive News & Ratings for Lanxess Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lanxess and related companies with MarketBeat.com's FREE daily email newsletter.